This page shows the latest F-Star news and features for those working in and with pharma, biotech and healthcare.
BMS taps F-star Alpha for immuno-oncology drug. Drug in development for breast and stomach cancers. ... F-star has its headquarters in Vienna but runs its research operations out of the Babraham Research Campus in Cambridge, UK.
f-star wins 15m investment. Antibody specialist f-star secures funding from existing investors and adds new members to its supervisory board. ... f-star, a company developing antibody-based products, has secured 15m of new financing.
During November and December 2010 there were five Big Pharma discovery deals involving Boehringer Ingelheim (with f-star), S-A (with Avila Therapeutics), Pfizer (with Phylogica), Tanabe Research Laboratories (with Anaphore) ... 286. Aires/Novartis.
These days you're lucky if you can give them a three-star hotel and a f ing biro. ... He also issued a thinly-veiled warning to any entrants who had been honoured with a highly commended': Congratulations and all that but stay in your f ing seat.
More from news
Approximately 1 fully matching, plus 3 partially matching documents found.
525. F-star Alpha/BMS. Option to acquire F-star Alpha. Includes FS102 a P1 ready treatment for HER2 positive patients with breast / gastric cancer.
This month is no exception with Bristol-Myers Squibb (BMS) securing an exclusive option to acquire F-star Alpha gaining access to its lead candidate FS102 for HER-2 positive patients
More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.
Edwards is currently executive chairman at F-star, having previously served as its chief executive officer, and brings over 30 years of biotechnology expertise from Adnexus Therapeutics, Genetics Institute/Wyeth and
F-star appoints vice president of protein sciences. Mike Davies joins from CPI Biologics. ... Vienna-headquartered biopharmaceutical company F-star has appointed Mike Davies as vice president of protein sciences at its Cambridge, UK research site.
Cambridge-based antibody research company F-Star has appointed Dr Neil Brewis as chief scientific officer. ... John Haurum CEO of F-Star, said: “ We are very pleased to welcome Neil to our team.
Grimster has extensive experience in advanced biologics development as has served in senior developments roles at businesses including F-star, Antisoma and Celltech.
More from appointments
Approximately 2 fully matching, plus 2 partially matching documents found.
Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...